MCM
TECX

MAI Capital Management’s Tectonic Therapeutic TECX Stock Holding History

MAI Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$217 – 4865
2026
Q1 		$217 Buy
+7
New +$172 ﹤0.01% 4605

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

MAI Capital Management's TECX Position: Q2 2026 in Review

MAI Capital Management sold out of Tectonic Therapeutic (TECX) in Q2 2026, closing a stake of 7 shares — an estimated $217 sold.

MAI Capital Management first reported a position in TECX in Q1 2026 and held it in 1 quarter. The position peaked at $217 in Q1 2026. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • MAI Capital Management reported no remaining Tectonic Therapeutic position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 7 Tectonic Therapeutic shares in Q2 2026, an estimated $217.
  • MAI Capital Management first reported a position in Tectonic Therapeutic in Q1 2026 and held it in 1 quarter.
  • MAI Capital Management's Tectonic Therapeutic position peaked at $217 in Q1 2026.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.